Trial
NCT00443261
Azacitidine and Cisplatin for Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck
Phase ITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
University of Kansas Medical Center
Collaborators
Celgene Corporation
Condition
Squamous Cell Carcinoma
Intervention
Azacitidine
Why stopped
Accrual problems
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2017-02-27